TMO vs CAH
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | CAH |
|---|---|---|
| Price | $700.22 | $281.10 |
| Market cap | $259.44B | $64.97B |
| P/E ratio | 36.9 | 36.4 |
| ROE | 13.38% | — |
| Profit margin | 14.94% | 0.70% |
| Revenue growth | 9.10% | 5.50% |
| Dividend yield | 0.27% | 0.73% |
| Beta | 0.84 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs CAH in plain English
- TMO is the bigger company — about 4.0× the market cap of CAH.
- CAH is cheaper on earnings (P/E 36.4 vs 36.9).
- TMO is growing revenue faster (9% vs 6%).
- CAH has the higher dividend yield (0.73% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.